Joint Formulary & PAD

Allergovit (pollen) - Allergen immunotherapy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Allergovit - RSFT Immunology only.

 

Status 2

Red
Formulations :
  • Sub-lingual drops
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Oralvac Compact drops - RSFT Immunology only

 

Status 3

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Pollinex quattro - RSFT Immunology only

 

Status 4

Red
Formulations :
  • Sublingual tablets
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Lais tablets (grass pollen) - RSFT immunology only

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Allergovit (pollen)
Indication :
Allergen immunotherapy
Group Name :
Keywords :
Pollen allergy
Brand Names Include :
Allergovit, Oralvac Compatc, Pollinex quattro, Lais
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
4

Other Indications

Below are listed other indications that Allergovit (pollen) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Allergen immunotherapy.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.